Kimia Bioscien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
32.35
0.55 (1.73%)
BSENSE

Jun 18

BSE+NSE Vol: 1.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Achyut Healthcar
Lactose (India)
Parnax Lab
Bal Pharma
Alpa Laboratorie
Tyche Industries
Panch.Organics
Kimia Bioscien.
Natural Capsules
Krebs Biochem
Accretion Pha.
Why is Kimia Biosciences Ltd ?
1
High Debt company with Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 1.32% and Operating profit at 16.97% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 14.13 times
  • The company has been able to generate a Return on Capital Employed (avg) of 9.76% signifying low profitability per unit of total capital (equity and debt)
2
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -15.23% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kimia Bioscien. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kimia Bioscien.
-29.98%
-0.20
76.81%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.84%
EBIT Growth (5y)
9.85%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
3.05
Sales to Capital Employed (avg)
2.36
Tax Ratio
12.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.38%
ROCE (avg)
7.35%
ROE (avg)
31.29%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
34
Price to Book Value
12.99
EV to EBIT
17.95
EV to EBITDA
13.02
EV to Capital Employed
3.96
EV to Sales
1.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.14%
ROE (Latest)
64.16%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 4.47 times

-10What is not working for the Company
PBT LESS OI(Q)

At Rs 0.75 cr has Fallen at -74.9% (vs previous 4Q average

PAT(Q)

At Rs 0.37 cr has Fallen at -83.6% (vs previous 4Q average

NET SALES(Q)

At Rs 27.20 cr has Fallen at -13.6% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 57.39 % of Profit Before Tax (PBT

EPS(Q)

Lowest at Rs 0.08

Loading Valuation Snapshot...
Here's what is working for Kimia Bioscien.
Debtors Turnover Ratio- Half Yearly
Highest at 4.47 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Kimia Bioscien.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 0.75 cr has Fallen at -74.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 2.99 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 0.37 cr has Fallen at -83.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.26 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 27.20 cr has Fallen at -13.6% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 31.48 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly
is 57.39 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.08
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)